VTR to Apply to be listed on GEM Again
Summary: VTR is ready to apply for getting listed on GEM again for the company's future
development in mid-2012.
Tags: VTR, Growth Enterprise Market, GEM, list, future development, heat resistant phytase,
neutral phtase, enzyme, feed additive, feed enzyme, feed phytase
Guangdong VTR Bio-Tech Co., Ltd. (VTR) is ready to apply for getting listed on the Growth
Enterprise Market (GEM) again for the company's future development in mid-2012, according to
CCM International’s February Issue of Industrial Biotechnology China News. Before, VTR had
applied for getting listed on GEM in April 2011, but unfortunately, it failed.
Aiming to be listed on GEM this time, according to the VTR's new company environmental
protection report in November 2011, it is claimed that the company has cut its fund raising
programs from 5 to 3. One is the program of heat resistant phytase's and neutral phtase's
technological improvement and their industrialization, and the other is the program of the
marketing network service's construction. Therefore, the sum of the raised fund decreases from
USD29.4 million to USD22.5 million. (TABLE) "Compared with the first failure, it is more optimistic
about the second time that VTR has the potential to be listed on GEM in mid-2012." says Mr. Luo,
Manager of VTR.
In fact, in April 2011, China Securities Regulatory Commission (CSRC) commented on VTR's first
listing failure mainly for the following three reasons. Firstly, the continued growth in accounts
receivable balances, which accounts highly for the company's total assets, may have the
potential risk of capital return. Besides, the decreasing sales volume of the company's main
products, feed compound enzymes, and the uncertainty of the increasing sales volume of feed
phytase would affect the company's business picture. The last main question is the uncertainty of
enzyme market digestion of the fund raising program of enzymes product expansion existed.
Mr. Luo explains that the company's listing project of this time has been done a little fixing in
connection with the CSRC's comment. As it mentioned above, the company has cut two fund
raising programs to raise the opportunity to be listed on GEM. Also, although the common feed
phytase market has been in over supply currently in China, Mr. Luo is confident on its company's
product sales, especially as its heat resistant phytase industrialization has become true. The
company has made some heat resistant comparisons on different brands heat resistant phytase
and it is concluded that the heat resistance of VTR's product is better than the other's, said by Mr.
Luo. Moreover, the company will launch its neutral phytase product in two years, which will make
the company consolidate its domestic feed phytase market share.
However, even CSRC complains about VTR's fund raising program of enzyme capacity
expansion, the company insists on the reservation of the enzyme capacity expansion attributed to
the phytase's bright future. The program is to construct the second phase of enzymes production
line with capacity of 12,000t/a, located in Inner Mongolia Autonomous Region. Actually, the
company that mainly produces phytase has the enzymes production line with capacity of 8,000t/a.
Mr. Luo is optimistic about the phytase's bright future mainly thanks to the rapid growth of
livestock and poultry industry. It is predicted that the meat consumption will be more substantial
with the improvement of farmers' income in some regions of China. The document named The
Twelfth Five-Year Plan of National Livestock and Poultry Genetic Resources Conservation and
Utilization claims that the proportion of large-scale breeding of livestock and poultry in the whole
nation will increase by 10%-15% by 2015. Phytase, which efficiently increase the animal dietary
phosphorus utilization so as to reduce the feeding cost, will become the active stock in the near
future.
VTR is a high-tech enterprise, which employs modern bioengineering technology and advanced
techniques of botanic extraction and is committed to research, development and manufacture of
feed additive and animal health products. Founded in 1991, the company is the first feed enzyme
enterprise integrating a complete network of R&D, manufacture and sales. The company has
achieved great progress and glories these years. In 2009, it drafted the determine method of feed
phytase activity and determine method of feed xylanase activity. In 2010, "Yiduozyme" was
authorized as the Famous Trademark in Guangdong Province.
Source: Industrial Biotechnology China News 1202
http://www.cnchemicals.com/Newsletter/NewsletterDetail_21.html
Main content of Industrial Biotechnology China News 1202:
Shenzhen Dingsanhua to invest in bioenergy
PGCG to invest in castor oil-based diesel in China
Guofeng Bioenergy to build a biodiesel plant in Anhui Province
Wuhan Kaidi biomass energy business relying on Chinese government's support
VTR to apply to be listed on GEM again
Trade analysis of butanol in China
L-phe domestic capacity expansion to launch in 2012
Shandong Polymer to construct a subsidiary company
Kingfa to launch a new PBS resin production line in October 2012
Arkema to purchase Suzhou HiPro and Hebei CASDA in early 2012
Trade analysis of PLA in China
Inner Mongolia Melic Sea to launch PPC production line in early 2013
……
Industrial Biotechnology China News, a monthly publication issued by CCM International on
8th of every month, focuses on biofuels, bio-products, bio-based chemicals, bio-materials and
industrial biotechnology applications, offers latest investment hotspots, new technology &
product, company & market dynamics, and government regulations, aiming to facilitate your
insight into China's industrial biotechnology.
About CCM
CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of
more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis,
Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new
proprietary product ValoTracer.
For more information, please visit http://www.cnchemicals.com.
CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou
510070, China
Tel: 86-20-37616606
Email: econtact@cnchemicals.com
Source: http://www.cnchemicals.com/PressRoom/PressRoomDetail_w_968.html